FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 18:46:04 23/05/2024 BST | ||
| 5.7 EUR | -22.76% |
|
| Current month | +25.51% | ||
| 1 month | +132.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 5.7 | -22.76% |
| 22/05/24 | 7.38 | -4.77% |
| 21/05/24 | 7.75 | -11.23% |
| 20/05/24 | 8.73 | +3.44% |
| 17/05/24 | 8.44 | -1.06% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 06:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BZ |
| ISIN | DE000HD36BZ3 |
| Date issued | 28/02/2024 |
| Strike | 193.1 $ |
| Maturity | Unlimited |
| Parity | 4.65 : 1 |
| Emission price | 11.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.96 € |
|---|---|
| Lowest since issue | 2.71 € |
| Spread | 0.24 € |
| Spread % | 4.07% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
